Cannabinoid Phenotypes in Cannabis sativa

Jacob Bell

New Member
ERNEST SMALL* & H. D. BECKSTEAD" 

*Biosystematics Research Institute, Department of Agriculture
" Health Protection Branch, Department of National Health and Welfare, Ottawa

Top of page
Abstract

IT has been suggested that "drug" strains and "non-drug" strains of Cannabis sativa L. comprise two comprehensive groups1,2, which can be identified on the basis of their relative content of two of the principal "cannabinoids". Drug strains have been thought to contain an excess, usually substantial, of (–)-Delta9-trans-tetrahydrocannabinol (Delta9-THC) in comparison with the amount of cannabidiol (CBD), including carboxylate forms of both compounds, and non-drug strains have been held to have the reverse ratio. The former compound is considered psychotomimetic (psychosis-imitating), whereas the latter is not3. In examining the above cannabinoid ratio to decide in which phenotypic group a strain belongs, some investigators2 add the amount of cannabinol (CBN) to the amount of THC. The former seems to be an oxidation product of Delta9-THC (ref. 4) and is not considered to be psychoactive.


Source: Cannabinoid Phenotypes in Cannabis sativa
 
Back
Top Bottom